Coronary Artery Disease and Its Association With Liver Steatosis Among HIV-Infected Persons
NCT00889577 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 233
Last updated 2023-03-21
Summary
The primary purpose of this study is to evaluate the association between nonalcoholic fatty liver disease (NAFLD) by computed tomography (CT) scan and coronary artery disease (CAD) measured by the calcium (CAC) score among HIV-infected persons.
Conditions
- HIV Infections
- Coronary Artery Disease
- Non-Alcoholic Fatty Liver Disease
Sponsors & Collaborators
-
Infectious Diseases Clinical Research Program
collaborator OTHER -
Henry M. Jackson Foundation for the Advancement of Military Medicine
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2008-12-31
- Primary Completion
- 2010-03-31
- Completion
- 2013-12-31
Countries
- United States
Study Locations
More Related Trials
-
The Gut, Liver And Metabolome in Human Immunodeficiency Virus and Non Alcoholic Fatty Liver Disease
NCT06113003 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1
-
Utilizing Computed Tomographic Angiography to Evaluate Coronary Artery Disease in Patients on Long-Term Antiretroviral Therapy
NCT02191306 ·Status: COMPLETED
-
Subclinical Atherosclerosis in HIV-infected Patients
NCT00455793 ·Status: COMPLETED
-
Prevalence and Predictors of Hepatic Steatosis in Persons Living With HIV
NCT04795219 ·Status: ACTIVE_NOT_RECRUITING
-
NAFLD in HIV-infected Patients
NCT04215926 ·Status: UNKNOWN
-
Coronary Artery Disease (CAD) in Suppressed HIV-infected
NCT02898896 ·Status: TERMINATED ·Phase: NA
-
Lifestyle Modification Programme for HIV-infected Individuals With Fatty Liver
NCT03913351 ·Status: UNKNOWN ·Phase: NA
-
Myocardial Function & FFA Metabolism in HIV Metabolic Syndrome
NCT00656851 ·Status: COMPLETED ·Phase: NA
-
Screening and Follow-up in Patients With HIV Infection Combined With Metabolic Associated Fatty Liver Disease
NCT05330923 ·Status: RECRUITING
-
HIV Infection And Evolvement of Atherosclerotic Plaque
NCT04810364 ·Status: UNKNOWN
-
Prevalence of Advanced Fibrosis in Patients Living With HIV
NCT04066608 ·Status: ENROLLING_BY_INVITATION
-
The Cleveland Cardiometabolic Cohort
NCT03059121 ·Status: COMPLETED
-
Inflammation, Viral Replication, and Atherosclerosis in Treated HIV Infection
NCT01519141 ·Status: COMPLETED
-
Nonalcoholic Fatty Liver Disease in HIV Database
NCT05023044 ·Status: ACTIVE_NOT_RECRUITING
-
A Prospective, Longitudinal Study of Endothelial Function in HIV/HCV Coinfected Subjects
NCT02597790 ·Status: COMPLETED
-
Antiretrovirals and Rate of Progression in Carotid Artery Intima-medial Thickness in HIV
NCT00575939 ·Status: COMPLETED
-
Liver Fibrosis in HIV-Infected Patients With Elevated Liver Enzymes on Antiretroviral Therapy
NCT00326482 ·Status: COMPLETED
-
Comparing Blood Vessel Endothelial Function in HIV-Infected People and Matched HIV-Uninfected People
NCT00919724 ·Status: COMPLETED
-
Factors Mediating Gut Microbiota Dysbiosis and Metabolic Disease in HIV Patients.
NCT02258685 ·Status: COMPLETED
-
Non-alcoholic Fatty Liver Disease (NAFLD) in HIV: The Role of Nutritional Interventions
NCT00152815 ·Status: TERMINATED ·Phase: PHASE2
-
The Effect of Anti-HIV Therapy on Fat Metabolism in HIV-Positive Patients
NCT00001102 ·Status: COMPLETED
-
Prevalence of Liver Fibrosis and Progression of Liver Fibrosis
NCT01208376 ·Status: UNKNOWN
-
Observational Study of Fat Loss in HIV Infected Adults Taking Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
NCT00119405 ·Status: COMPLETED
-
HIV-Associated Heart Disease
NCT00005229 ·Status: COMPLETED
-
Inflammatory Pathogenesis of Coronary Atherosclerosis in HIV
NCT02624180 ·Status: COMPLETED ·Phase: PHASE2